Literature DB >> 32011723

Scale-up of the Kerala Diabetes Prevention Program (K-DPP) in Kerala, India: implementation evaluation findings.

Ranjana Ravindranath1, Brian Oldenburg2,3, Sajitha Balachandran1, Gomathyamma Krishnakurup Mini1,4, Kishori Mahat5, Thirunavukkarasu Sathish5,6, Kavumpurathu Raman Thankappan1,7.   

Abstract

The cluster-randomized controlled trial of the Kerala Diabetes Prevention Program (K-DPP) demonstrated some significant improvements in cardiometabolic risk factors and other outcomes. We aimed to refine and improve K-DPP for wider implementation in the Kerala state of India. The specific objectives of the scale-up program were (a) to develop a scalable program delivery model and related capacity building in Kerala and (b) to achieve significant improvements in cardiometabolic risk factors in the target population. A total of 118 key trainers of a large women's organization trained 15,000 peer leaders in three districts of Kerala. Each of these peer leaders was required to deliver 12 monthly sessions to ~25 people, reaching an estimated total of 375,000 adults over 12 months. We evaluated the number of sessions conducted, the participation of men, and program reach. We also assessed the effectiveness of the program in a random sample of 1,200 adults before and after the intervention and performed a biochemical evaluation on a subsample of 321. Of the 15,222 peer leaders who were trained, 1,475 (9.7%) returned their evaluation forms, of which, 98% reported conducting at least 1 session, 88% ≥6 sessions, and 74% all 12 sessions. Tobacco use among men reduced from 30% to 25% (p = .02) and alcohol use from 40% to 32% (p = .001). Overall, mean waist circumference reduced from 89.5 to 87.5 cm (p < .001). Although there were some study shortcomings, the approach to scale-up and its implementation was quite effective in reaching a large population in Kerala and there were also some significant improvements in key cardiometabolic risk factors following the 1 year intervention. © Society of Behavioral Medicine 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Diabetes; India; K-DPP; Kerala; Scale-up

Year:  2020        PMID: 32011723     DOI: 10.1093/tbm/ibz197

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  4 in total

Review 1.  Prevention of Type 2 Diabetes.

Authors:  Mary Beth Weber; Saria Hassan; Rakale Quarells; Megha Shah
Journal:  Endocrinol Metab Clin North Am       Date:  2021-07-12       Impact factor: 4.748

Review 2.  Lifestyle Interventions for Diabetes Prevention in South Asians: Current Evidence and Opportunities.

Authors:  Mary Beth Weber; Unjali P Gujral; Ram Jagannathan; Megha Shah
Journal:  Curr Diab Rep       Date:  2021-06-07       Impact factor: 4.810

3.  Lifestyle Changes Observed among Adults Participating in a Family- and Community-Based Intervention for Diabetes Prevention in Europe: The 1st Year Results of the Feel4Diabetes-Study.

Authors:  Yannis Manios; Christina-Paulina Lambrinou; Christina Mavrogianni; Greet Cardon; Jaana Lindström; Violeta Iotova; Tsvetalina Tankova; Imre Rurik; Vicky Van Stappen; Jemina Kivelä; Rocío Mateo-Gallego; Luis Α Moreno; Konstantinos Makrilakis; Odysseas Androutsos
Journal:  Nutrients       Date:  2020-06-30       Impact factor: 5.717

4.  Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.

Authors:  Thirunavukkarasu Sathish; Brian Oldenburg; Kavumpurathu R Thankappan; Pilvikki Absetz; Jonathan E Shaw; Robyn J Tapp; Paul Z Zimmet; Sajitha Balachandran; Suman S Shetty; Zahra Aziz; Ajay Mahal
Journal:  BMC Med       Date:  2020-09-04       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.